Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Danone S.A.

Start price
Target price
Perf. (%)
€53.42
06.07.22
€60.00
06.07.23
7.30%
30.05.23

buy
Pilgrims Pride

Start price
Target price
Perf. (%)
€30.00
28.06.22
-
28.06.23
-39.33%
28.06.23

buy
Imperial Brands plc

Start price
Target price
Perf. (%)
€20.61
14.06.22
-
14.06.23
-0.29%
14.06.23

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€1.36
12.06.22
-
12.06.23
-6.76%
27.09.22

Could be very worthwhile Investment >20% year
buy
Sanderson Farms Inc.

Start price
Target price
Perf. (%)
€186.00
07.06.22
-
07.06.23
6.45%
07.06.23

buy
British American Tobacco PLC

Start price
Target price
Perf. (%)
€42.35
26.05.22
€50.00
02.06.24
-18.77%
09.02.23

Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€2.87
16.05.22
-
16.05.23
-15.82%
24.05.22

Probably not worthwhile Investment
Very high cyclical dependencies
Below average Marketposition
Higher risks for its business
buy
Lotus Bakeries NV

Start price
Target price
Perf. (%)
€4,755.0
11.05.22
€6,000.0
11.05.23
34.60%
11.05.23

Could be worthwhile Investment >10% per year
Some uniques
Growths faster than the competition
buy
MedAvail Holdings Inc.

Start price
Target price
Perf. (%)
€2.10
09.05.22
€3.30
09.05.23
-18.57%
16.05.22

Could be very worthwhile Investment >20% year
buy
BayWa AG NA

Start price
Target price
Perf. (%)
€64.00
04.05.22
€70.00
04.05.23
-8.13%
04.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
Capable Management
buy
BayWa AG VNA

Start price
Target price
Perf. (%)
€46.65
03.05.22
-
03.05.23
-18.33%
03.05.23

buy
MedAvail Holdings Inc.

Start price
Target price
Perf. (%)
€1.88
02.05.22
€32.00
02.05.23
-24.47%
02.06.22

Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
buy
Pernod-Ricard S.A.

Start price
Target price
Perf. (%)
€196.65
02.05.22
€220.00
02.05.23
8.26%
03.05.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Archer-Daniels-Midland Co.

Start price
Target price
Perf. (%)
€85.21
02.05.22
€99.00
02.05.23
-19.26%
03.05.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Park & Bellheimer AG

Start price
Target price
Perf. (%)
€1.66
29.04.22
-
29.04.23
8.43%
30.04.23

Coca-Cola Co.

Start price
Target price
Perf. (%)
€62.88
28.04.22
€54.00
28.04.23
-6.79%
29.04.23

Small Risks for its business
Market Leader or Top 3
Well known brand
Undervalued
buy
Campbell Soup Co.

Start price
Target price
Perf. (%)
€44.87
28.04.22
€50.00
01.09.22
7.15%
09.05.22

buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.20
19.04.22
-
12.04.26
-88.73%
16.02.24

Could be worthwhile Investment >10% per year
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€3.20
18.04.22
-
18.04.23
-10.28%
30.04.22

Could be very worthwhile Investment >20% year
MedAvail Holdings Inc.

Start price
Target price
Perf. (%)
€2.76
16.04.22
€0.000
16.04.23
-44.57%
30.04.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Berentzen Gruppe AG

Start price
Target price
Perf. (%)
€6.76
16.04.22
-
16.04.23
-3.85%
30.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
buy
Südzucker AG

Start price
Target price
Perf. (%)
€12.79
16.04.22
-
16.04.23
-3.36%
30.04.22

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Future proof or reliable business model
Top 10 in its market
MedAvail Holdings Inc.

Start price
Target price
Perf. (%)
€1.98
11.04.22
€0.000
11.04.23
39.39%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.

Start price
Target price
Perf. (%)
€1.98
11.04.22
€0.000
11.04.23
-5.05%
02.05.22

Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
buy
Nestlé S.A..

Start price
Target price
Perf. (%)
€91.00
08.04.22
-
08.04.23
-
16.11.22